Discover
SPRB
Spruce Biosciences, Inc.
52.55
3 x 51.10
2 x 54.00
bid
ask
-
1.45
2.69%
3 @ 04:00 PM
53.00 +0.45 (0.87%)
| Ytd | -39.68% | |
| 1y | -86.84% |
50.86
day range
54.94
7.00
52 week range
838.13
| Open | 54.00 | Prev Close | 54.00 | Low | 50.86 | High | 54.94 | Mkt Cap | 144.62M |
| Vol | 52.77K | Avg Vol | 76.67K | EPS | -35.82 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 2.37 | Short Ratio | 0.10 | Inst. Own | 46.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 53.01 | 200-d Avg | 73.45 | 1yr Est | 1.83 |
| Income Statement | |||
| Operating Expenses | 11.99M | ||
| Research and Development Expense | 7.58M | ||
| Selling, General and Administrative Expense | 4.41M | ||
| Operating Income | -11.99M | ||
| Interest Expense | 674.00K | ||
| Net Income | -12.27M | ||
| Net Income Common Stock | -12.27M | ||
| Net Income Common Stock (USD) | -12.27M | ||
| Consolidated Income | -12.27M | ||
| Earnings per Basic Share | -8.94 | ||
| Earnings per Basic Share (USD) | -8.94 | ||
| Earnings per Diluted Share | -8.94 | ||
| Earning Before Interest & Taxes (EBIT) | -11.59M | ||
| Earning Before Interest & Taxes (USD) | -11.59M | ||
| Weighted Average Shares | 1.37M | ||
| Weighted Average Shares Diluted | 1.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 54.08M | ||
| Cash and Equivalents (USD) | 54.08M | ||
| Current Assets | 55.03M | ||
| Property, Plant & Equipment Net | 595.00K | ||
| Total Assets | 56.17M | ||
| Debt Current | 1000.00K | ||
| Total Debt | 6.80M | ||
| Current Liabilities | 11.78M | ||
| Debt Non-Current | 5.80M | ||
| Total Liabilities | 21.52M | ||
| Accumulated Retained Earnings (Deficit) | -301.50M | ||
| Shareholders Equity | 34.65M | ||
| Shareholders Equity (USD) | 34.65M | ||
| Assets Non-Current | 1.13M | ||
| Total Debt (USD) | 6.80M | ||
| Liabilities Non-Current | 9.73M | ||
| Trade and Non-Trade Payables | 2.68M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 323.00K | ||
| Net Cash Flow from Financing | 13.92M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.17M | ||
| Capital Expenditure | -10.00K | ||
| Issuance (Repayment) of Debt Securities | 14.15M | ||
| Net Cash Flow from Investing | -10.00K | ||
| Net Cash Flow from Operations | -8.73M | ||
| Share Based Compensation | 689.00K | ||